1. A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis. Issue 3 (28th February 2021) Authors: Gindin, Yevgeniy; Chung, Chuhan; Jiang, Zhaoshi; Zhou, Jing Zhu; Xu, Jun; Billin, Andrew N.; Myers, Robert P.; Goodman, Zachary; Landi, Abdolamir; Houghton, Michael; Green, Richard M.; Levy, Cynthia; Kowdley, Kris V.; Bowlus, Christopher L.; Muir, Andrew J.; Trauner, Michael Journal: Hepatology Issue: Volume 73:Issue 3(2021) Page Start: 1105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH. Issue 1 (17th January 2023) Authors: Xu, Jun; Wang, Ya; Khoshdeli, Mina; Peach, Matt; Chuang, Jen‐Chieh; Lin, Julie; Tsai, Wen‐Wei; Mahadevan, Sangeetha; Minto, Wesley; Diehl, Lauri; Gupta, Ruchi; Trauner, Michael; Patel, Keyur; Noureddin, Mazen; Kowdley, Kris V.; Gulamhusein, Aliya; Bowlus, Christopher L.; Huss, Ryan S.; Myers, Rob... Journal: Hepatology Issue: Volume 77:Issue 1(2023) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lack of evidence for GDF11 as a rejuvenator of aged skeletal muscle satellite cells. Issue 3 (28th March 2016) Authors: Hinken, Aaron C.; Powers, Janine M.; Luo, Guizhen; Holt, Jason A.; Billin, Andrew N.; Russell, Alan J. Journal: Aging cell Issue: Volume 15:Issue 3(2016) Page Start: 582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD. Issue 6 (23rd June 2022) Authors: Smirnova, Ekaterina; Muthiah, Mark D.; Narayan, Nicole; Siddiqui, Mohamad S.; Puri, Puneet; Luketic, Velimir A.; Contos, Melissa J.; Idowu, Michael; Chuang, Jen‐Chieh; Billin, Andrew N.; Huss, Ryan S.; Myers, Robert P.; Boyett, Sherry; Seneshaw, Mulugeta; Min, Hae‐Ki; Mirshahi, Faridodin; Sanyal,... Journal: Hepatology Issue: Volume 76:Issue 6(2022) Page Start: 1811 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteers. Issue 3 (15th January 2023) Authors: Younis, Islam R.; Kirby, Brian J.; Billin, Andrew N.; Xiao, Deqing; Song, Qinghua; Watkins, Timothy R.; Othman, Ahmed A. Journal: Clinical and translational science Issue: Volume 16:Issue 3(2023) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Semi‐Mechanistic PK/PD Modeling and Simulation of Irreversible BTK Inhibition to Support Dose Selection of Tirabrutinib in Subjects with RA. Issue 2 (27th October 2021) Authors: Meng, Amy; Humeniuk, Rita; Jürgensmeier, Juliane M.; Hsueh, Chia‐Hsiang; Matzkies, Franziska; Grant, Ethan; Truong, Hoa; Billin, Andrew N.; Yu, Helen; Feng, Joy; Kwan, Ellen; Tarnowski, Thomas; Nelson, Cara H. Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 2(2022) Page Start: 416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis. Issue 3 (10th March 2019) Authors: Trauner, Michael; Gulamhusein, Aliya; Hameed, Bilal; Caldwell, Stephen; Shiffman, Mitchell L.; Landis, Charles; Eksteen, Bertus; Agarwal, Kosh; Muir, Andrew; Rushbrook, Simon; Lu, Xiaomin; Xu, Jun; Chuang, Jen‐Chieh; Billin, Andrew N.; Li, Georgia; Chung, Chuhan; Subramanian, G. Mani; Myers, Robe... Journal: Hepatology Issue: Volume 70:Issue 3(2019) Page Start: 788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗